thiazoles has been researched along with Growth Disorders in 6 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (33.33) | 29.6817 |
| 2010's | 1 (16.67) | 24.3611 |
| 2020's | 3 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| DeBoer, MD; Donowitz, JR; Elwood, SE; Gratz, J; Houpt, ER; Jatosh, S; Katengu, S; Kivuyo, S; McDermid, JM; Mdoe, P; Mduma, E; Parpia, TC; Platts-Mills, JA; Rogawski McQuade, ET; Scharf, RJ; Svensen, E; Swann, JR; Wanjuhi, AW | 1 |
| Alesandrini, M; Aubert, H; Blanc, T; Boddaert, N; Boutry, N; Branle, F; Broissand, C; Canaud, G; Catteau, B; Chapelle, C; Degrugillier-Chopinet, C; Domanski, O; Dubos, F; Fraissenon, A; Guibaud, L; Han, TK; Herbreteau, G; Hoguin, C; Mezel, A; Morin, G; Petit, F; Sarnacki, S; Vincent, M | 1 |
| Garreta Fontelles, G; Grande Moreillo, C; Pardo Pastor, J | 1 |
| Hobernicht, SL; Hunger, SP; Schweiger, B; Wang, M; Zeitler, P | 1 |
| Harding, CO; Held, P | 1 |
| Braun, M; Brenner, RE; Debatin, KM; Hauner, H; Heinze, E; Melzner, I; Möller, P; Wabitsch, M | 1 |
1 trial(s) available for thiazoles and Growth Disorders
| Article | Year |
|---|---|
Effect of scheduled antimicrobial and nicotinamide treatment on linear growth in children in rural Tanzania: A factorial randomized, double-blind, placebo-controlled trial.
Topics: Adult; Anti-Infective Agents; Azithromycin; Child Development; Double-Blind Method; Drug Administration Schedule; Female; Growth Disorders; Humans; Infant; Infant, Newborn; Intestinal Diseases, Parasitic; Niacinamide; Nitro Compounds; Pregnancy; Tanzania; Thiazoles | 2021 |
5 other study(ies) available for thiazoles and Growth Disorders
| Article | Year |
|---|---|
Treatment of two infants with PIK3CA-related overgrowth spectrum by alpelisib.
Topics: Biomarkers; Class I Phosphatidylinositol 3-Kinases; Diagnostic Imaging; Disease Management; Disease Susceptibility; Female; Growth Disorders; Humans; Infant; Male; Phenotype; Thiazoles; Treatment Outcome | 2022 |
Alpelisib to treat CLOVES syndrome, a member of the PIK3CA-related overgrowth syndrome spectrum.
Topics: Catalytic Domain; Class I Phosphatidylinositol 3-Kinases; Growth Disorders; Humans; Lipoma; Musculoskeletal Abnormalities; Mutation; Nevus; Phosphatidylinositol 3-Kinase; Phosphatidylinositol 3-Kinases; Proto-Oncogene Proteins c-akt; Syndrome; Thiazoles; Vascular Malformations | 2022 |
Acquired growth hormone deficiency in a girl with chronic myelogenous leukemia treated with tyrosine kinase inhibitor therapy.
Topics: Benzamides; Child; Dasatinib; Diseases in Twins; Female; Growth Disorders; Human Growth Hormone; Humans; Imatinib Mesylate; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Piperazines; Protein Kinase Inhibitors; Pyrimidines; Thiazoles | 2011 |
L-2-oxothiazolidine-4-carboxylate supplementation in murine gamma-GT deficiency.
Topics: Animals; Body Weight; Dietary Supplements; gamma-Glutamyltransferase; Genotype; Glutathione; Growth Disorders; Liver; Mice; Mice, Knockout; Pyrrolidonecarboxylic Acid; Reproduction; Thiazoles; Thiazolidines | 2003 |
Characterization of a human preadipocyte cell strain with high capacity for adipose differentiation.
Topics: Adipocytes; Adipose Tissue; Cell Differentiation; Cell Division; Cells, Cultured; Female; Gene Expression; Glypicans; Growth Disorders; Heparan Sulfate Proteoglycans; Humans; Infant; Insulin; Karyotyping; Leptin; Male; Models, Biological; Receptors, Cytoplasmic and Nuclear; Rosiglitazone; Syndrome; Thiazoles; Thiazolidinediones; Transcription Factors | 2001 |